359 related articles for article (PubMed ID: 7937312)
1. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
[TBL] [Abstract][Full Text] [Related]
2. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB
Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593
[TBL] [Abstract][Full Text] [Related]
3. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
Raffa RB; Jacoby HI
Peptides; 1989; 10(4):873-5. PubMed ID: 2587427
[TBL] [Abstract][Full Text] [Related]
4. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
[TBL] [Abstract][Full Text] [Related]
5. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
Rothman RB; Brady LS; Xu H; Long JB
Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
[TBL] [Abstract][Full Text] [Related]
6. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
7. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord.
Gouardères C; Tafani JA; Zajac JM
Peptides; 1998; 19(4):727-30. PubMed ID: 9622028
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
9. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
10. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
13. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
15. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
16. Identifiable Achatina giant neurones: their localizations in ganglia, axonal pathways and pharmacological features.
Takeuchi H; Araki Y; Emaduddin M; Zhang W; Han XY; Salunga TL; Wong SM
Gen Pharmacol; 1996 Jan; 27(1):3-32. PubMed ID: 8742492
[TBL] [Abstract][Full Text] [Related]
17. The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores.
Mansour A; Hoversten MT; Taylor LP; Watson SJ; Akil H
Brain Res; 1995 Nov; 700(1-2):89-98. PubMed ID: 8624732
[TBL] [Abstract][Full Text] [Related]
18. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
19. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
20. Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain.
Ni Q; Xu H; Partilla JS; Rice KC; Matecka D; Calderon SN; Porreca F; Lai J; Schmidhammer H; Krassnig R; Rothman RB
Peptides; 1998; 19(6):1079-90. PubMed ID: 9700759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
